1.
Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.
2.
3.
4.
5.
6.
7.
Implementation of indication-based pricing (10 th scenario) for daratumumab and pembrolizumab.
Input parameters for the base-case analysis.
Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.
Seawater carbonate chemistry and oxygen uptake rates of coral reef fishes
40 Years of Dutch Disease Literature: Lessons for Developing Countries
8.
9.
Distribution of the eight sampling locations along the coasts of Belgium, the Netherlands (Eems-Dollard estuary), and United Kingdom (Suffolk coast) within the southern North Sea,...
Boxplot of PLD excluded of the yolk sac larval phase predicted for Belgium (BE), the Netherlands (NL) and the United Kingdom (UK) for the period 1995 to 2015.
Differential item functioning graphs.
Data material.
